Trial Profile
Factors associated with adherence in a cohort of HIV positive subjects on a first time PI [protease inhibitor] containing HAART regimen: observational study of the impact of adherence on viral load for a HAART regimen containing Kaletra [lopinavir/ritonavir] vs other selected PI containing HAART
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Antiretrovirals; HIV protease inhibitors
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Abbott Laboratories
- 19 Nov 2008 Status changed from completed to discontinued, according to clinicaltrials.gov.
- 17 Dec 2007 Status changed from in progress to completed.
- 26 Jun 2007 New trial record.